Bio-Techne Corp
NASDAQ: TECH · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-04-29
Bio-Techne Corp (TECH) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for TECH.
Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.
TECH historical valuation range
Where current P/E sits in TECH's own 5Y range.
TECH intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
TECH valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 98.02x
P/S Ratio — History
Current: 6.69x
Is TECH overvalued in 2026?
Bio-Techne Corp (TECH) currently trades at $51.95 per share with a market capitalization of $8,127,749,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 48/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 98.0x, above its 5-year median of 85.0x. The PEG ratio of 0.69 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Looking at its own history, TECH is currently trading more expensive than 60% of the last 5Y on P/E. This places it in the 60th percentile of its historical range, a reasonable but unremarkable position.
Our discounted cash flow model estimates TECH's intrinsic value at $212.04 per share, against the current market price of $51.95. This implies a margin of safety of +70.08%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
Financial quality is a concern. The Piotroski F-Score of 3/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.
Bottom line: TECH appears richly valued on our framework, with a Smart Value Score of 48/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.
Frequently asked questions
Is TECH overvalued in 2026?
Based on a Smart Value Score of 48/100, TECH appears overvalued. Current price exceeds what fundamentals currently justify.
What is TECH's fair value?
Our DCF model estimates TECH's intrinsic value at $212.04 per share, versus the current price of $51.95. This produces a margin of safety of +70.08%.
What P/E ratio does TECH trade at?
TECH trades at a P/E of 98.0x on trailing twelve-month earnings, compared to its 5-year median of 85.0x.
Is TECH a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 48/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.
How does TECH's valuation compare to its history?
On P/E, TECH currently sits in the 60th percentile of its own 5Y range. That is above its long-run median relative to where it has traded over the period.
What is TECH's Smart Value Score?
TECH's Smart Value Score is 48/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.